series-a
Stage
1
Investors
About
Palobiofarma is a biopharmaceutical company focused on discovering and developing innovative drugs based on selective adenosine receptor modulators for rare and orphan diseases.
Explore Palobiofarma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.